We previously reported the effects of high-flow nasal cannula (HFNC) oxygen therapy on thoraco-abdominal synchrony. This study was designed to clarify the effect of HFNC on thoraco-abdominal synchrony in pediatric subjects after cardiac surgery and to investigate HFNC optimal flow in this population.
METHODS:
Thoraco-abdominal synchrony was evaluated with respiratory inductive plethysmography. After extubation, we delivered oxygen via face mask for 30 min to subjects with mild to moderate respiratory failure. Each subject then randomly received either 1 or 2 L/kg/min via HFNC for 30 min, followed by the other flow level via HFNC for 30 min. After HFNC, face mask delivery was resumed. Rib cage and abdominal movement were converted into volumes and 2 quantitative indexes: maximum compartmental amplitude/tidal volume (VT) ratio and phase angle.
RESULTS:
Ten subjects of median (interquartile range) age 7 (6–14) months and weighing 6.5 (5.3–8.8) kg were enrolled. Compared with the first delivery via face mask, breathing frequency, maximum compartmental amplitude/VT, phase angle, and minute volume significantly decreased at 2 L/kg/min (P < .05 for all) but not at 1 L/kg/min. PaCO2 did not differ among oxygen therapies. None of the measured variables differed between first and second face mask periods.
CONCLUSIONS:
After cardiac surgery, HFNC oxygen therapy at 2 L/kg/min improved thoraco-abdominal synchrony and decreased breathing frequency in pediatric subjects. (Clinical trial registration: UMIN000023426.)
NishimuraM. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care, 2016; 61(4):529–541.
2.
LevySD, AlladinaJW, HibbertKA, HarrisRS, BajwaEK, HessDR. High-flow oxygen therapy and other inhaled therapies in intensive care units. Lancet, 2016; 387(10030):1867–1878.
3.
NedelWL, DeutschendorfC, Moraes Rodrigues FilhoE. High-flow nasal cannula in critically ill subjects with or at risk for respiratory failure: a systematic review and meta-analysis. Respir Care, 2017; 62(1):123–132.
4.
WardJJ. High-flow oxygen administration by nasal cannula for adult and perinatal patients. Respir Care, 2013; 58(1):98–122.
5.
FratJP, ThilleAW, MercatA, GiraultC, RagotS, PerbetS, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med, 2015; 372(23):2185–2196.
6.
BaudinF, PouyauR. High-flow nasal cannula in the pediatric ICU: popular or efficient?. Respir Care, 2017; 62(8):1116–1117.
7.
RamnarayanP, SchiblerA. Glass half empty or half full? The story of high-flow nasal cannula therapy in critically ill children. Intensive Care Med, 2017; 43(2):246–249.
ChikataY, IzawaM, OkudaN, ItagakiT, NakatakiE, OnoderaM, et al. Humidification performance of two high-flow nasal cannula devices: a bench study. Respir Care, 2014; 59(8):1186–1190.
10.
ChikataY, OhnishiS, NishimuraM. Humidity and inspired oxygen concentration during high-flow nasal cannula therapy in neonatal and infant lung models. Respir Care, 2017; 62(5):532–537.
11.
ParkeRL, McGuinnessSP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care, 2013; 58(10):1621–1624.
12.
UrbanoJ, del CastilloJ, López-HerceJ, GallardoJA, SolanaMJ, CarrilloÁ. High-flow oxygen therapy: pressure analysis in a pediatric airway model. Respir Care, 2012; 57(5):721–726.
13.
MöllerW, CelikG, FengS, BartensteinP, MeyerG, OliverE, et al. Nasal high flow clears anatomical dead space in upper airway models. J Appl Physiol, 2015; 118(12):1525–1532.
14.
FrizzolaM, MillerTL, RodriguezME, ZhuY, RojasJ, HesekA, et al. High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung injury model. Pediatr Pulmonol, 2011; 46(1):67–74.
15.
ChikataY, OnoderaM, OtoJ, NishimuraM. FIO2 in an adult model simulating high-flow nasal cannula therapy. Respir Care, 2017; 62(2):193–198.
16.
PhamTM, O'MalleyL, MayfieldS, MartinS, SchiblerA. The effect of high flow nasal cannula therapy on the work of breathing in infants with bronchiolitis. Pediatr Pulmonol, 2015; 50(7):713–720.
17.
SchiblerA, PhamTM, DunsterKR, FosterK, BarlowA, GibbonsK, HoughJL. Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery. Intensive Care Med, 2011; 37(5):847–852.
18.
MilésiC, BaleineJ, MateckiS, DurandS, CombesC, NovaisAR, CambonieG. Is treatment with a high flow nasal cannula effective in acute viral bronchiolitis? A physiologic study. Intensive Care Med, 2013; 39(6):1088–1094.
19.
TobinMJ, JenouriG, LindB, WatsonH, SchneiderA, SacknerMA. Validation of respiratory inductive plethysmography in patients with pulmonary disease. Chest, 1983; 83(4):615–620.
20.
de JonghBE, LockeR, MackleyA, EmbergerJ, BostickD, StefanoJ, et al. Work of breathing indices in infants with respiratory insufficiency receiving high-flow nasal cannula and nasal continuous positive airway pressure. J Perinatol, 2014; 34(1):27–32.
21.
ItagakiT, OkudaN, TsunanoY, KohataH, NakatakiE, OnoderaM, et al. Effect of high-flow nasal cannula on thoraco-abdominal synchrony in adult critically ill patients. Respir Care, 2014; 59(1):70–74.
22.
LockeRG, WolfsonMR, ShafferTH, RubensteinSD, GreenspanJS. Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics, 1993; 91(1):135–138.
23.
SaslowJG, AghaiZH, NakhlaTA, HartJJ, LawryshR, StahlGE, PyonKH. Work of breathing using high-flow nasal cannula in preterm infants. J Perinatol, 2006; 26(8):476–480.
24.
NielsenKR, EllingtonLE, GrayAJ, StanberryLI, SmithLS, DiBlasiRM. Effect of high-flow nasal cannula on expiratory pressure and ventilation in infant, pediatric, and adult models. Respir Care, 2018; 63(2):147–157.
25.
LuoJC, LuMS, ZhaoZH, JiangW, XuB, WengL, et al. Positive end-expiratory pressure effect of 3 high-flow nasal cannula devices. Respir Care, 2017; 62(7):888–895.
26.
SacknerMA, WatsonH, BelsitoAS, FeinermanD, SuarezM, GonzalezG, et al. Calibration of respiratory inductive plethysmograph during natural breathing. J Appl Physiol, 1989; 66(1):410–420.
27.
DysartK, MillerTL, WolfsonMR, ShafferTH. Research in high flow therapy: mechanisms of action. Respir Med, 2009; 103(10):1400–1405.
28.
LeeJH, RehderKJ, WillifordL, CheifetzIM, TurnerDA. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med, 2013; 39(2):247–257.
29.
SivieriEM, GerdesJS, AbbasiS. Effect of HFNC flow rate, cannula size, and nares diameter on generated airway pressures: an in vitro study. Pediatr Pulmonol, 2013; 48(5):506–514.
30.
GappaM, PillowJJ, AllenJ, MayerO, StocksJ. Lung function tests in neonates and infants with chronic lung disease: Lung and chest-wall mechanics. Pediatr Pulmonol, 2006; 41(4):291–317.
31.
ColettiKD, BagdureDN, WalkerLK, RemyKE, CusterJW. High flow nasal cannula utilization in pediatric critical care. Respir Care, 2017; 62(8):1023–1029.
32.
RitchieJE, WilliamsAB, GerardC, HockeyH. Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care, 2011; 39(6):1103–1110.
33.
ParkeRL, BlochA, McGuinnessSP. Effect of very-high-flow nasal therapy on airway pressure and end-expiratory lung impedance in healthy volunteers. Respir Care, 2015; 60(10):1397–1403.
34.
HasanRA, HabibRH. Effects of flow rate and airleak at the nares and mouth opening on positive distending pressure delivery using commercially available high-flow nasal cannula systems: a lung model study. Pediatr Crit Care Med, 2011; 12(1):e29–e33.
35.
VolskoTA, FedorK, AmadeiJ, ChatburnRL. High flow through a nasal cannula and CPAP effect in a simulated infant model. Respir Care, 2011; 56(12):1893–1900.
36.
MauriT, AlbanL, TurriniC, CambiaghiB, CarlessoE, TacconeP, et al. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med, 2017; 43(10):1453–1463.
37.
SztrymfB, MessikaJ, BertrandF, HurelD, LeonR, DreyfussD, RicardJD. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med, 2011; 37(11):1780–1786.
38.
SztrymfB, MessikaJ, MayotT, LengletH, DreyfussD, RicardJD. Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study. J Crit Care, 2012; 27(3):324.e9–e13.
39.
RocaO, RieraJ, TorresF, MasclansJR. High-flow oxygen therapy in acute respiratory failure. Respir Care, 2010; 55(4):408–413.
40.
CorleyA, CaruanaLR, BarnettAG, TronstadO, FraserJF. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth, 2011; 107(6):998–1004.
41.
LamplandAL, PlummB, MeyersPA, WorwaCT, MammelMC. Observational study of humidified high-flow nasal cannula compared with nasal continuous positive airway pressure. J Pediatr, 2009; 154(2):177–182.
